Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
BMJ Case Reports|September 3, 2025
A possible protective role of pigment proliferation against subretinal neovascularisation progression in idiopathic macular telangiectasia type IISagar Agarwal, Madhurima A Nayak
Molecular Pharmaceutics|February 17, 2012
Insight into the cooperation of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) at the blood-brain barrier: a case study examining sorafenib efflux clearanceSagar Agarwal, William F Elmquist
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 22, 2012
Brain distribution and bioavailability of elacridar after different routes of administration in the mouseRamola Sane, Sagar Agarwal, William F Elmquist
BMJ Case Reports|May 12, 2025
Multimodal imaging in autosomal recessive Stargardt's diseaseSagar Agarwal, Madhurima A Nayak, Shilpa Sood
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 9, 2013
Brain efflux index to investigate the influence of active efflux on brain distribution of pemetrexed and methotrexateLi Li, Sagar Agarwal, William F Elmquist
The Journal of Pharmacology and Experimental Therapeutics|February 11, 2012
Brain distribution of cediranib is limited by active efflux at the blood-brain barrierTianli Wang, Sagar Agarwal, William F Elmquist
BMJ Case Reports|May 9, 2024
Acute macular neuroretinopathy following Valsalva manoeuvre: an insight into the pathophysiologySagar Agarwal, Madhurima A Nayak, Saurabh Luthra, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 2013
Saturable active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier leads to nonlinear distribution of elacridar to the central nervous systemRamola Sane, Sagar Agarwal, Rajendar K Mittapalli, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 2010
The role of the breast cancer resistance protein (ABCG2) in the distribution of sorafenib to the brainSagar Agarwal, Ramola Sane, John R Ohlfest, et al.
Current Pharmaceutical Design|August 11, 2011
Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team upSagar Agarwal, Anika M S Hartz, William F Elmquist, et al.
Pageof 3